Cytokinetics Inc

Healthcare · Biotechnology

64.70$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,425 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CYTK
Line item	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	61	79	56	63	128	91	170	155	87	123	78	53	78	83	133	115	170	295	211	290	534	841	1,015	824	1,402	1,425
Current Assets	–	–	28	37	109	79	154	122	59	117	73	51	76	79	131	113	159	274	208	234	474	536	795	628	1,108	917
Cash	–	–	16	11	13	14	39	117	42	26	18	19	15	20	20	65	67	125	42	36	83	113	66	113	95	123
Cash & Short-Term Investments	–	–	27	35	106	76	110	120	57	115	72	49	74	78	83	111	156	269	199	225	464	472	783	615	1,076	882
Receivables	–	–	0.0	0.3	0.8	0.7	42	0.2	0.3	0.2	0.0	0.0	0.0	0.0	47	0.0	0.0	1.1	6.8	5.2	4.4	52	0.1	1.3	17	18
Inventory	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.8	–	-4.4	-52	-0.1	-12	–	–
Property, Plant & Equipment	–	–	9.7	8.9	7.3	6.2	9.2	7.7	5.1	3.7	2.3	1.3	1.0	1.2	1.6	1.8	3.6	3.6	3.2	4.5	13	73	80	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–
Total Liabilities	83	116	117	155	21	18	63	55	38	21	7.5	4.6	6.1	29	41	47	76	185	185	301	420	597	1,123	1,211	1,537	2,084
Current Liabilities	–	–	9.4	9.5	11	11	26	26	23	20	7.3	4.6	5.8	27	24	32	33	32	22	26	31	72	85	103	180	202
Short-Term Debt	–	–	2.4	2.0	2.4	2.7	3.7	4.1	2.0	1.6	0.8	0.2	1.4	3.7	1.4	2.2	2.5	5.3	2.6	4.6	2.8	15	14	28	30	60
Accounts Payable	–	–	1.6	1.6	2.1	2.4	2.8	1.6	1.4	1.7	1.1	1.2	2.2	3.7	1.4	2.2	4.2	5.3	3.8	8.2	8.1	21	26	22	20	22
Long-Term Debt	–	–	7.1	8.1	8.1	6.6	7.1	4.6	2.6	1.0	0.2	0.0	0.0	0.0	0.0	15	27	32	40	45	46	47	64	607	646	1,116
Shareholders' Equity	-22	-37	-61	-92	108	74	106	100	50	101	71	48	71	54	92	69	94	110	26	-11	113	244	-108	-386	-135	-660
Retained Earnings	-22	-38	-61	-94	-131	-174	-231	-280	-336	-311	-361	-409	-449	-483	-497	-535	-518	-646	-743	-865	-992	-1,208	-1,586	-2,112	-2,702	-3,487
Shares Outstanding	0.2	0.2	0.3	0.3	3.3	4.8	6.1	7.9	8.2	9.7	11	12	18	27	36	39	43	49	54	58	65	77	90	97	112	120

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings